SCHEMBL22749223

SCHEMBL22749223

CCCCNc1cnn(C)c1C(=O)OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 1/20 0.48
▸ KDM6B O15054 1/20 0.43
▸ KDM4C Q9H3R0 1/20 0.43
▸ CYP1A2 P05177 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ FLT1 P17948 6/20 0.41
▸ KDR P35968 6/20 0.41
▸ KDM4E B2RXH2 3/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ RIPK1 Q13546 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ LMNA P02545 2/20 0.39
▸ PDE5A O76074 1/20 0.39
▸ PDE4B Q07343 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ GMNN O75496 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22749207 0.96 CNR2 (0.47) CNR2KDM6BKDM4CCYP1A2CYP2C19
SCHEMBL19893277 0.84 CNR2 (0.47) CNR2CYP1A2CYP2C19FLT1KDR
SCHEMBL22749197 0.81 ALDH1A1 (0.40) CNR2KDM6BKDM4CCYP1A2CYP2C19
SCHEMBL30908549 0.75 CNR2 (0.59) CNR2CYP1A2CYP2C19FLT1KDR
SCHEMBL1881753 0.75 CNR2 (0.55) CNR2CYP1A2CYP2C19FLT1KDR
SCHEMBL27409311 0.73 CNR2 (0.56) CNR2CYP1A2CYP2C19FLT1KDR
SCHEMBL22749175 0.72 CNR2 (0.47) CNR2KDM6BKDM4CKDM4ESMN1; SMN2
SCHEMBL9982691 0.72 KDM4E (0.64) CNR2KDM4ESMN1; SMN2RAB9A
SCHEMBL12723401 0.71 RIPK1 (0.47) KDM6BKDM4CCYP1A2CYP2C19KDM4E
SCHEMBL2215634 0.71 CNR2 (0.47) CNR2CYP1A2CYP2C19KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12358919-B2 Antibacterial compounds UNIVERSITA' DEGLI STUDI DI SIENA (IT) 2025-07-15 — — US disclosed
US-20220235059-A1 ANTIBACTERIAL COMPOUNDS UNIVERSITA' DEGLI STUDI DI SIENA (IT) 2022-07-28 — — US disclosed
EP-3980418-A1 ANTIBACTERIAL COMPOUNDS Universita' Degli Studi di Siena (IT) 2022-04-13 — — EP disclosed
WO-2020245759-A1 ANTIBACTERIAL COMPOUNDS UNIVERSITA' DEGLI STUDI DI SIENA (IT) 2020-12-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12358919-B2 Antibacterial compounds ABCB11, CFTR, MRPL21 CNR2 4529/4885KDM6B 3403/4885KDM4C 3554/4885
US-20220235059-A1 ANTIBACTERIAL COMPOUNDS ABCB11, CFTR, MRPL21 CNR2 4529/4885KDM6B 3403/4885KDM4C 3554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback